We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+21.99%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$137M
AUM Growth
+$6.74M
Cap. Flow
-$9.94M
Cap. Flow %
-7.27%
Top 10 Hldgs %
36.21%
Holding
88
New
23
Increased
19
Reduced
22
Closed
20

Top Buys

Rank Stock Value
1
HAPN
Happen Inc
HAPN
+$2.9M
2
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$2.73M
3
CNC icon
Centene
CNC
+$1.87M
4
HUM icon
Humana
HUM
+$1.76M
5
LULU icon
lululemon athletica
LULU
+$1.71M

Top Sells

Rank Stock Value
1
MLM icon
Martin Marietta Materials
MLM
+$3.69M
2
EXP icon
Eagle Materials
EXP
+$2.85M
3
SCTY
SolarCity Corporation
SCTY
+$2.44M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$2.41M
5
NFLX icon
Netflix
NFLX
+$2.35M

Sector Composition

Rank Sector Weight
1 Healthcare 40.81%
2 Consumer Discretionary 12.34%
3 Communication Services 11.33%
4 Industrials 11.3%
5 Financials 4.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRUB
51
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$890K 0.65%
+12,250
New +$865K
BHC icon
52
CALL
Bausch Health
BHC
$2.58B
$858K 0.63%
+6,000
New +$807K
GMCR
53
DELISTED
KEURIG GREEN MTN INC
GMCR
$794K 0.58%
6,000
-9,000
-60% -$1.28M
OMER icon
54
Omeros
OMER
$857M
$768K 0.56%
+31,000
New +$565K
CAB
55
DELISTED
Cabela's Inc
CAB
$764K 0.56%
+14,500
New +$762K
BMRN icon
56
BioMarin Pharmaceuticals
BMRN
$11.6B
$723K 0.53%
+8,000
New +$665K
KATE
57
DELISTED
Kate Spade & Company
KATE
$704K 0.51%
+22,000
New +$628K
HQY icon
58
HealthEquity
HQY
$8.41B
$702K 0.51%
27,600
-8,400
-23% -$182K
JUNO
59
DELISTED
Juno Therapeutics, Inc.
JUNO
$679K 0.5%
+13,000
New +$582K
INCY icon
60
Incyte
INCY
$24.2B
$621K 0.45%
+8,500
New +$555K
COO icon
61
Cooper Companies
COO
$14.1B
$486K 0.36%
12,000
-20,000
-63% -$803K
PBYI icon
62
Puma Biotechnology
PBYI
$404M
$473K 0.35%
+2,500
New +$555K
EHTH icon
63
CALL
eHealth
EHTH
$42.2M
$446K 0.33%
+17,900
New +$435K
NBIX icon
64
Neurocrine Biosciences
NBIX
$16.8B
$335K 0.24%
+15,000
New +$284K
SLXP
65
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$287K 0.21%
2,500
-7,500
-75% -$909K
CORV
66
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$131K 0.1%
14,213
– –
ACAD icon
67
CALL
Acadia Pharmaceuticals
ACAD
$4.43B
$102K 0.07%
3,200
– –
JVA icon
68
Coffee Holding Co
JVA
$19.5M
$94K 0.07%
18,400
-51,600
-74% -$284K
ELV icon
69
Elevance Health
ELV
$81.5B
– –
-12,000
Closed -$1.44M
ENPH icon
70
Enphase Energy
ENPH
$4.96B
– –
-63,000
Closed -$944K
EXP icon
71
Eagle Materials
EXP
$6.29B
– –
-28,000
Closed -$2.85M
GOGO icon
72
Gogo Inc
GOGO
$565M
– –
-25,000
Closed -$422K
HEES
73
DELISTED
H&E Equipment Services
HEES
– –
-33,500
Closed -$1.35M
MLM icon
74
Martin Marietta Materials
MLM
$31.5B
– –
-28,625
Closed -$3.69M
NFLX icon
75
Netflix
NFLX
$299B
– –
-365,400
Closed -$2.35M
1 2
3
4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Atika Capital Management held 88 positions worth $137M, up 5.2% from $130M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Atika Capital Management withdrew a net $9.94M in Q4 2014, closing 20 positions and reducing 22 holdings. Its most notable exit was Martin Marietta Materials, an estimated $3.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Atika Capital Management opened a new position in Happen Inc worth $2.91M.

  • Atika Capital Management's largest Q4 2014 buy was Happen Inc: 23,000 shares worth $2.91M.
  • Atika Capital Management added most to RECEPTOS INC COM STK (DE) in Q4 2014, an estimated $2.73M increase.
  • Atika Capital Management's biggest Q4 2014 reduction was Agios Pharmaceuticals, cutting an estimated $2.41M.
  • Atika Capital Management fully exited Martin Marietta Materials in Q4 2014, selling an estimated $3.69M.
  • Atika Capital Management's ten largest holdings make up 36% of its $137M portfolio in Q4 2014.
  • Atika Capital Management opened 23 new positions and closed 20 in Q4 2014.
  • Atika Capital Management's portfolio value rose 5.2% quarter-over-quarter to $137M.

Based on Atika Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.